18/07/2022
https://m.facebook.com/story.php?story_fbid=5904258819603382&id=100000579674558
87% Survival – New Combined Therapy Greatly Improves Prostate Cancer Survival
A Cedars-Sinai cancer study indicates improved survival following a combination of hormone therapy and pelvic lymph node treatment A combination of androgen deprivation therapy—a common hormone injection—and pelvic lymph node radiotherapy prevented prostate cancer from therapy in nearly 90% of c...
14/06/2022
State hospitals worst hit by brain drain, NMA laments
The Nigerian Medical Association has decried the deplorable state of health facilities owned by state governments.
19/05/2022
https://youtu.be/IPoQpoX9i8c
Health: ASMEDA Urges F.G. To Focus More On Developing Infrastructure | NEWS
The National President of the Association of Specialists’ Medical Doctor on Academics, ASMEDA, OLUGBENGA AYANNUGA has stressed the need to focus more on deve...
15/04/2022
Experimental injection may repair spinal cord injuries, animal study suggests
Mice that were paralyzed due to severe spinal cord damage regained the ability to walk within four weeks of receiving an experimental injectable therapy, a new study found.
14/04/2022
Cannabis: how it affects our cognition and psychology – new research
Cannabis use is linked to poorer memory, attention and mental health.
07/04/2022
New Cell Type Discovered Deep in Human Lungs – With Regenerative Properties
Findings shine light on underpinnings of COPD, pave new direction for future research on treatments. A new type of cell that resides deep within human lungs and may play a key role in human lung diseases has been discovered by researchers at the Perelman School of Medicine at the University of Pe
25/03/2022
Pfizer recalls some high blood pressure drugs over possible cancer risk
The company recalled six lots of its Accuretic tablets, as well as authorized generics distributed by Greenstone.
25/03/2022
Male Contraceptive Pill Found 99% Effective in Mice, With No Observable Side Effects
A team of scientists said Wednesday they had developed a male oral contraceptive that was 99 percent effective in mice and didn't cause observable side effects, with the drug expected to enter human trials by the end of this year.